Latest filing published 14 Sept 2026 for Puma Biotechnology, INC., €39k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Wilson Troy Edward discloses dealings in Puma Biotechnology, Inc. to SEC (Form 4). Between 12 June 2026 and 14 September 2026, the trades on record add up to 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 14 September 2026: a transaction of €39k, in Puma Biotechnology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations